Eric Chapoulaud

Title: The Innovations of Eric Chapoulaud in Particle Analysis Technology

Introduction

Eric Chapoulaud, an inventive force hailing from Pasadena, CA, has made significant strides in the realm of scientific innovation. With a portfolio of 10 patents, he has contributed notably to the field of particle analysis, particularly in urine sample analysis. His work not only showcases his technical prowess but also highlights the importance of innovation in medical diagnostics.

Latest Patents

Eric's latest patents include groundbreaking technologies such as flowcell systems and autofocus methods for particle analysis in urine samples. These innovations involve a detailed apparatus designed to analyze particle-containing samples efficiently. The particle imaging system incorporates a flowcell through which urine samples flow, coupled with a high optical resolution imaging device that captures images for detailed analysis. A contrast pattern is cleverly integrated for autofocus capabilities, enabling precise focus accuracy assessments from pixel data contrast. The positioning motor in the system allows for adjustments along the optical axis, ensuring the microscope and flowcell remain focused on the sample stream. This sophisticated combination allows for continuous image collection, thereby enhancing accuracy and reliability in particle analysis.

Career Highlights

Throughout his career, Eric has been associated with prominent companies, including Iris International, Inc. and Ormco Corporation. These professional experiences have enriched his understanding and expertise in the technological aspects of diagnostic equipment, making him a valuable contributor to the field. His relentless pursuit of innovation has led to several patents that are instrumental in modern diagnostic practices.

Collaborations

Eric has worked alongside remarkable colleagues such as Craig A. Andreiko and Mark A. Payne. Their collaboration has fostered a dynamic environment for creativity and innovation, further propelling advancements in medical technology. Working in tandem with such accomplished professionals demonstrates Eric's commitment to collaborative innovation and the sharing of ideas within the industry.

Conclusion

In conclusion, Eric Chapoulaud's innovative contributions to particle analysis, particularly in the context of urine sample analysis, exemplify the critical role of inventors in advancing technology in medical diagnostics. His extensive patent portfolio reflects a dedication to improving the processes involved in sample analysis. As the field continues to evolve, Eric's innovations stand as a testament to the ingenuity that drives progress in science and technology.